cover2

Monday, 11 March 2019 09:07

Cover 2 Podcast: Week of 03/16/19

Written by
Rate this item
(0 votes)

When a key member of the government’s legal team went to work for the pharmaceutical industry, the job of diversion control enforcement changed dramatically. In this episode, Mr. Joseph Rannazzisi, who for over a decade, was the front man in the government’s battle against the opioid epidemic, shares a first-hand account of what happened when Congress took the word of an industry attorney over an agency that was actually enforcing the law.

Today, in the third part of our 4-part series, you’ll hear more of Mr. Rannazzisi’s unfiltered comments on the passage of the Ensuring Patient Access and Effective Enforcement Act and the Congressional leaders behind it.  “This doesn’t ensure patient access and it doesn’t help drug enforcement at all. What this bill does has nothing to do with the medical process. What this bill does is take away DEA’s ability to go after a pharmacist, a wholesaler, manufacturer or distributor,” he said. “This was a gift. A gift to the industry.”  

Greg is joined on this episode by guest, award-winning author of “American Overdose”, Chris McGreal. McGreal’s book is a comprehensive portrait of the greed, corruption and indifference that led our country into the worst health crisis in American history. Additionally, Mr. McGreal is an investigative journalist for the Guardian, who in 2016, wrote a compelling story about Mr. Rannazzisi titled “Opioid epidemic: ex-DEA official says Congress is protecting drug makers.”  
https://www.theguardian.com/us-news/2016/oct/31/opioid-epidemic-dea-official-congress-big-pharma

Listen to this podcast, the third in our 4 part series, for more candid conversation with the former head of the Department of Diversion Control for the DEA, Mr. Joseph Rannazzisi.

Read 168 times